CELLDEX THERAPEUTICS INC NEW's ticker is CLDXXXXX and the CUSIP is 15117B103. A total of 136 filers reported holding CELLDEX THERAPEUTICS INC NEW in Q1 2017. The put-call ratio across all filers is 1.19 and the average weighting 0.7%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2018 | $2,000 | 0.0% | 4,000 | 0.0% | 0.00% | 0.0% |
Q2 2018 | $2,000 | -77.8% | 4,000 | 0.0% | 0.00% | -66.7% |
Q1 2018 | $9,000 | -18.2% | 4,000 | 0.0% | 0.00% | -25.0% |
Q4 2017 | $11,000 | 0.0% | 4,000 | 0.0% | 0.00% | -20.0% |
Q3 2017 | $11,000 | +10.0% | 4,000 | 0.0% | 0.01% | 0.0% |
Q2 2017 | $10,000 | -28.6% | 4,000 | 0.0% | 0.01% | -28.6% |
Q1 2017 | $14,000 | 0.0% | 4,000 | 0.0% | 0.01% | 0.0% |
Q4 2016 | $14,000 | – | 4,000 | – | 0.01% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
TSP Capital Management Group, LLC | 844,981 | $15,421,000 | 7.11% |
DOHENY ASSET MANAGEMENT /CA | 195,345 | $3,565,000 | 1.70% |
First Light Asset Management, LLC | 153,617 | $2,804,000 | 1.59% |
Rhenman & Partners Asset Management AB | 175,000 | $3,194,000 | 0.93% |
Iguana Healthcare Management, LLC | 100,000 | $1,825,000 | 0.88% |
Eventide Asset Management | 288,700 | $5,269,000 | 0.58% |
Bedell Frazier Investment Counselling, LLC | 60,820 | $1,110,000 | 0.54% |
STONERIDGE INVESTMENT PARTNERS LLC | 214,327 | $3,911,000 | 0.52% |
Fernwood Investment Management, LLC | 31,350 | $572,000 | 0.49% |
SUFFOLK CAPITAL MANAGEMENT LLC | 168,560 | $3,076,000 | 0.37% |